0001104659-19-042699.txt : 20190730 0001104659-19-042699.hdr.sgml : 20190730 20190730192243 ACCESSION NUMBER: 0001104659-19-042699 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190726 FILED AS OF DATE: 20190730 DATE AS OF CHANGE: 20190730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: van der Velden Peter CENTRAL INDEX KEY: 0001778046 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37619 FILM NUMBER: 19986908 MAIL ADDRESS: STREET 1: C/O EDESA BIOTECH INC. STREET 2: 100 SPY COURT CITY: MARKHAM STATE: A6 ZIP: L3R 5H6 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lumira Capital Investment Management Inc. CENTRAL INDEX KEY: 0001702636 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37619 FILM NUMBER: 19986909 BUSINESS ADDRESS: STREET 1: 141 ADELAIDE STREET WEST STREET 2: SUITE 770 CITY: TORONTO STATE: A6 ZIP: M5H 3L5 BUSINESS PHONE: 416-213-4223 MAIL ADDRESS: STREET 1: 141 ADELAIDE STREET WEST STREET 2: SUITE 770 CITY: TORONTO STATE: A6 ZIP: M5H 3L5 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edesa Biotech, Inc. CENTRAL INDEX KEY: 0001540159 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 100 SPY COURT CITY: MARKHAM STATE: A6 ZIP: L3R 5H6 BUSINESS PHONE: (905) 475-1234 MAIL ADDRESS: STREET 1: 100 SPY COURT CITY: MARKHAM STATE: A6 ZIP: L3R 5H6 FORMER COMPANY: FORMER CONFORMED NAME: Stellar Biotechnologies, Inc. DATE OF NAME CHANGE: 20120120 4 1 a4.xml 4 X0306 4 2019-07-26 0 0001540159 Edesa Biotech, Inc. EDSA 0001778046 van der Velden Peter C/O EDESA BIOTECH, INC. 100 SPY COURT MARKHAM A6 L3R 5H6 ONTARIO, CANADA 1 0 1 0 0001702636 Lumira Capital Investment Management Inc. C/O EDESA BIOTECH, INC. 100 SPY COURT MARKHAM A6 L3R 5H6 ONTARIO, CANADA 0 0 1 0 Common Shares 2019-07-26 4 A 0 93006 0.00 A 1704344 I Held by Lumira Capital II, L.P. Common Shares 2019-07-26 4 A 0 8600 0.00 A 157599 I Held by Lumira Capital II (International), L.P. Represents additional common shares of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.) (the "Issuer") issued pursuant to the post-closing adjustment contemplated by that certain Share Exchange Agreement, dated as of March 7, 2019, by and among the Issuer, Edesa Biotech, Inc. ("Edesa"), and the shareholders of Edesa. The closing of the share exchange transaction contemplated by the Share Exchange Agreement occurred on June 7, 2019, at which time the Issuer acquired all the outstanding capital shares of Edesa from the Edesa shareholders. All share numbers reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019. This Form 4 is jointly filed by (i) Lumira Capital II, L.P. ("LCII LP"), (ii) Lumira Capital II (International), L.P. ("LCII INT LP"), (iii) Lumira Capital GP, L.P., (iv) Lumira GP Inc., (v) Lumira GP Holdings Co., and (vi) Lumira Capital Investment Management Inc. Lumira Capital GP, L.P., the general partners of which are Lumira GP Inc. and Lumira GP Holdings Co., is the general partner of LCII LP and LCII INT LP, and each of LCII LP and LCII INT LP is managed by Lumira Capital Investment Management Inc. Mr. van der Velden is an executive officer of Lumira GP Inc., Lumira GP Holdings Co., and Lumira Capital Investment Management Inc. Each of Lumira Capital GP, L.P., Lumira GP Inc., Lumira GP Holdings Co., Lumira Capital Investment Management Inc. and Mr. van der Velden may be deemed to beneficially own the shares held by LCII LP and LCII INT LP, but each disclaim beneficial ownership except to the extent of their pecuniary interest therein, if any. /s/ Peter van der Velden 2019-07-30 LUMIRA CAPITAL INVESTMENT MANAGEMENT INC. By: /s/ Vasco Larcina Name: Vasco Larcina Title: VP Finance 2019-07-30